Liu, G., Nadal, E., Baijal, S., Bulotta, A., Baik, C. S., Thurm, H. C., Polli, A., Nishio, M. (2025). Impact of lorlatinib dose modifications on adverse event outcomes in the phase 3 CROWN study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8590